EUVIMEDEUVIMED entdecken
Kohortenstudie

Hemithyroidectomy Versus Total Thyroidectomy for Sporadic Medullary Thyroid Cancer: A Chinese Nationwide Large-Scale Cohort Study

Xiao Shi, Cenkai Shen, Chuqiao Liu, Likun Zhang, Yuxin Du, Hao Zhang, Hongwei Liu, Jianbiao Wang, Chuang Chen, Yijun Wu, Chunyan Zhang, Zimeng Li und 22 weitere

Journal of the National Comprehensive Cancer Network · 2025-03 · 23 (3) · 105-112

DOI: 10.6004/jnccn.2024.7088 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2025-03. Verfasst von Xiao Shi und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Sha…. Hauptthemen laut MEDLINE: Thyroidectomy, Thyroid Neoplasms, Carcinoma, Neuroendocrine. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Medullary thyroid cancer (MTC) is a rare thyroid malignancy, with 70% to 80% of cases being sporadic (sMTC). Current guidelines recommend total thyroidectomy (TT) for all preoperatively suspicious sMTC, though there has been increasing support for reducing the surgical extent in recent years. However, relevant data are limited. This study aimed to comprehensively evaluate the safety of hemithyroidectomy (HT) in sMTC. Patients and Methods: This study included 797 patients with MTC who received curative-intent initial surgery at 19 participating referral centers. Genetic testing was performed to identify disease heredity. We evaluated the safety of HT in sMTC across 5 aspects: (1) prevalence of occult bilateral foci, (2) prevalence of contralateral lobe recurrence, (3) biochemical response, (4) structural recurrence-free survival (SRFS), and (5) overall survival (OS).

Results

Of the 797 patients, 648 were genetically confirmed as having sMTC. HT and TT were performed as the index surgery in 232 (35.8%) and 416 (64.2%) patients, respectively. In the TT group, bilateral foci were found in 34 (8.2%) patients, of whom only 10 (2.4%) had sonographically occult foci, and of these, only 3 (0.72%) had a maximal tumor size ≤2 cm. In the HT group, only 1.7% (4/232) had recurrence in the preserved lobe, with only 1 (0.43%) having a maximal tumor size ≤2 cm. After propensity score matching, 230 pairs of patients were included in further analysis. No significant differences were found in OS (log-rank: P =.484; Cox regression: P =.380), SRFS (log-rank: P =.914; Cox regression: P =.309), or biochemical response (chi-square: P =.744; logistic regression: P =.818) between the 2 groups. Subgroup analyses showed that HT conferred comparable structural and biochemical outcomes with TT in small (≤2 cm) sMTCs, even for patients with high-risk factors such as high preoperative calcitonin, multifocal disease, lymph node metastases, RET M918T mutation, and desmoplasia.

Conclusions

For small unilateral sMTCs, HT may be considered an alternative treatment that does not compromise prognosis while avoiding additional complications associated with TT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThyroidectomyThyroid NeoplasmsCarcinoma, NeuroendocrineHumansFemaleMaleMiddle AgedAdultChinaAgedNeoplasm Recurrence, LocalTreatment OutcomeYoung AdultRetrospective StudiesEast Asian People

Autor:innen und Institutionen

  • Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Department of Pathology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Department of Head and Neck Surgery, Liaoning Cancer Hospital & Institute, Shenyang, China.
  • Department of Head and Neck Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, China.

Zitieren

APA

Shi, X., Shen, C., Liu, C., Zhang, L., Du, Y., Zhang, H., Liu, H., Wang, J., Chen, C., Wu, Y., Zhang, C., Li, Z., Tang, H., Yin, M., Mao, X., Liu, S., Sun, Y., Zhou, Y., Wei, W., …, & Wang, Y. (2025). Hemithyroidectomy Versus Total Thyroidectomy for Sporadic Medullary Thyroid Cancer: A Chinese Nationwide Large-Scale Cohort Study. Journal of the National Comprehensive Cancer Network, 23(3), 105-112. https://doi.org/10.6004/jnccn.2024.7088

Vancouver

Shi X, Shen C, Liu C, Zhang L, Du Y, Zhang H, et al. Hemithyroidectomy Versus Total Thyroidectomy for Sporadic Medullary Thyroid Cancer: A Chinese Nationwide Large-Scale Cohort Study. Journal of the National Comprehensive Cancer Network. 2025;23(3):105-112. doi:10.6004/jnccn.2024.7088

BibTeX
@article{Shi2025,
  author = {Shi, Xiao and Shen, Cenkai and Liu, Chuqiao and Zhang, Likun and Du, Yuxin and Zhang, Hao and Liu, Hongwei and Wang, Jianbiao and Chen, Chuang and Wu, Yijun and Zhang, Chunyan and Li, Zimeng and Tang, Haitao and Yin, Min and Mao, Xiaoqi and Liu, Shuyi and Sun, Yaoting and Zhou, Yan and Wei, Wenjun and Huang, Naisi and Wang, Zhihong and Gui, Zhiqiang and Liu, Hanqing and Wang, Jiaxi and Li, Jian and Li, Cuiwei and Xiang, Shiyu and Guo, Liang and Zhang, Yan and He, Yi and Guo, Tiannan and Ji, Qinghai and Liu, Zhiyan and Wang, Yu},
  title = {Hemithyroidectomy Versus Total Thyroidectomy for Sporadic Medullary Thyroid Cancer: A Chinese Nationwide Large-Scale Cohort Study},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2025},
  volume = {23},
  number = {3},
  pages = {105--112},
  doi = {10.6004/jnccn.2024.7088}
}
Kostenlos starten →